Fig. 2.
Comparison of circulating Th17 cells in ALL (a) and AML (b) patients before and after chemotherapy. Th17 cells were reduced significantly in responders compared to their levels before treatment
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.